News
CEMI
0.4550
0.00%
0.0000
*Biosynex Completes Acquisition Of Chembio Diagnostics, Inc. CEMI
Dow Jones · 04/27/2023 20:30
Press Release: Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Dow Jones · 04/27/2023 20:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)
TipRanks · 04/27/2023 12:40
Wrap Technologies And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Benzinga · 04/26/2023 11:21
Brightcove And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
Benzinga · 04/21/2023 11:23
Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex
PR Newswire · 04/20/2023 15:48
Press Release: Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
Dow Jones · 04/19/2023 12:00
Press Release: Chembio Stockholders Urged to -2-
Dow Jones · 04/19/2023 12:00
NN And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Benzinga · 04/18/2023 11:57
Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
Benzinga · 04/14/2023 12:49
Craig-Hallum Sticks to Its Buy Rating for Chembio Diagnostics (CEMI)
TipRanks · 04/13/2023 13:15
Biosynex again extends tender offer for Chembio acquisition
Seeking Alpha · 04/13/2023 11:37
BRIEF-Biosynex Extends Tender Offer For Shares Of Chembio Diagnostics
Reuters · 04/13/2023 11:09
Press Release: Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Dow Jones · 04/13/2023 11:00
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
MT Newswires · 04/13/2023 09:06
BRIEF-Chembio Diagnostics Inc - Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement
Reuters · 04/06/2023 20:47
*Chembio: CEO Letter to Stockholders
Dow Jones · 04/03/2023 20:24
*Chembio Diagnostics CEO Richard Eberly: On Behalf of Myself, the Executive Team and the Bd of Directors, We Strongly Support the Merger With Biosynex >CEMI
Dow Jones · 04/03/2023 20:24
Press Release: Chembio's CEO Letter to Stockholders
Dow Jones · 04/03/2023 20:15
Press Release: Chembio's CEO Letter to -2-
Dow Jones · 04/03/2023 20:15
More
Webull provides a variety of real-time CEMI stock news. You can receive the latest news about Chembio Diagnostics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CEMI
Chembio Diagnostics, Inc. is a diagnostics company. The Company is focused on developing and commercializing point-of-care tests used to detect and diagnose infectious diseases, including sexually transmitted diseases, insect vectors and tropical diseases, coronavirus disease (COVID-19), and other viral and bacterial infections, enabling expedited treatment. The Company's DPP technology offers broad market applications beyond infectious disease. The DPP platform can detect and differentiate up to eight distinct test results from a single patient sample. Its DPP Micro Reader optical analyzers can report results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on site. Its products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.